Search Results - "Korman, N.J."

Management of psoriasis as a systemic disease: what is the evidence? by Korman, N.J.

“…Summary Background Psoriasis is a chronic, systemic immune‐mediated disease characterized by development of erythematous, indurated, scaly, pruritic and often…”
Get full text

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3) by Papp, K.A., Leonardi, C.L., Blauvelt, A., Reich, K., Korman, N.J., Ohtsuki, M., Paul, C., Ball, S., Cameron, G.S., Erickson, J., Zhang, L., Mallbris, L., Griffiths, C.E.M.

“…Summary Background Ixekizumab, a high‐affinity monoclonal antibody that selectively targets interleukin (IL)‐17A, is approved for the treatment of…”
Get full text

Efficacy of Secukinumab in patients with Plaque Psoriasis: area under the curve of treatment response rates by Armstrong, A.W, Feldman, S.R, Korman, N.J, Meng, X, Guana, A, Nyirady, J, Herrera, V, Zhao, Y

Get full text

358 The association of patient income levels and prescribing patterns of psoriasis therapies in the medical expenditure panel survey by Eley, S.J., DeMeo, D.P., Korman, N.J., Carroll, B.T.

Get full text

Tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: long‐term safety and efficacy in an open‐label extension study by Valenzuela, F., Korman, N.J., Bissonnette, R., Bakos, N., Tsai, T.‐F., Harper, M.K., Ports, W.C., Tan, H., Tallman, A., Valdez, H., Gardner, A.C.

“…Summary Background Tofacitinib is an oral Janus kinase inhibitor. Final safety and efficacy data from an open‐label extension study of tofacitinib in psoriasis…”
Get full text

Guidelines of care for the management of psoriasis and psoriatic arthritis Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies by MENTER, Alan, KORMAN, Neil J, VAN VOORHEES, Abby S, BEUTNER, Karl R, BHUSHAN, Reva, ELMETS, Craig A, FELDMAN, Steven R, GELFAND, Joel M, GORDON, Kenneth B, GOTTLIEB, Alice, KOO, John Y. M, LEBWOHL, Mark, LIM, Henry W

“…Psoriasis is a common, chronic, inflammatory, multi-system disease with predominantly skin and joint manifestations affecting approximately 2% of the…”
Get full text

伊赛珠单抗对银屑病的治疗:三项双盲对照研究的综合药效分析(发现-1、发现-2、发现-3) by Papp, K.A., Leonardi, C.L., Blauvelt, A., Reich, K., Korman, N.J., Ohtsuki, M., Paul, C., Ball, S., Cameron, G.S., Erickson, J., Zhang, L., Mallbris, L., Griffiths, C.E.M.

Get full text

PSS4 - Efficacy of Secukinumab in patients with Plaque Psoriasis: area under the curve of treatment response rates by Armstrong, A.W., Feldman, S.R., Korman, N.J., Meng, X., Guana, A., Nyirady, J., Herrera, V., Zhao, Y.

Get full text

Ixekizumab treatment for psoriasis: integrated efficacy analysis of three double‐blinded, controlled studies (UNCOVER‐1, UNCOVER‐2, UNCOVER‐3) by Papp, K.A., Leonardi, C.L., Blauvelt, A., Reich, K., Korman, N.J., Ohtsuki, M., Paul, C., Ball, S., Cameron, G.S., Erickson, J., Zhang, L., Mallbris, L., Griffiths, C.E.M.

“…Summary Psoriasis is a disease that causes the skin to form thick scales that get red, itchy, and dry. About 2–4% of the Western population has psoriasis. We…”
Get full text

Paraneoplastic pemphigus: the first case report from Japan by Nishibori, Y, Hashimoto, T, Ishiko, A, Shimizu, H, Korman, N J, Nishikawa, T

“…Paraneoplastic pemphigus is a rare skin disease characterized by painful mucosal ulcerations and polymorphous skin lesions in association with an underlying…”
Get more information

Mortalité dans la pemphigoïde bulleuse: méta-analyse sur données individuelles de 12 études internationales by Tedbirt, B., Andrieu, E., Ezzedine, K., Korman, N.J., Tang, M., Li, J., Borradori, L., Soo-Chan, K., Gual, A., Xiao, T., Wieland, C.N., Fairley, J., Joly, P.

“…Le taux de mortalité de la pemphigoïde bulleuse (PB) reste controversé. Plusieurs études européennes rapportent des taux de mortalité 2 à 6 fois supérieurs à…”
Get full text

伊赛珠单抗对银屑病的治疗:三项双盲对照研究的综合药效分析(发现‐1、发现‐2、发现‐3) by Papp, K.A., Leonardi, C.L., Blauvelt, A., Reich, K., Korman, N.J., Ohtsuki, M., Paul, C., Ball, S., Cameron, G.S., Erickson, J., Zhang, L., Mallbris, L., Griffiths, C.E.M.

“…Summary…”
Get full text

Paraneoplastic pemphigus: potential therapeutic effect of plasmapheresis by Izaki, S., Yoshizavva, Y., Kitamura, K., Kato, H., Hashimoto, H., Korman, N.J., Hamamatsu, Y., Ohashi, N., Ogasa, S.

Get full text

065 Postembedding immunogold electron microscopy of in situ bound IgG from the skin of patients with bullous pemphigoid by Ishiko, A., Shimizu, H., Hashimoto, T., Nishikawa, T., Korman, N.J.

Get full text